Healthcare Equipment and Supplies
Company Overview of Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc., a medical device company, engages in the development and commercialization of particle-based therapy devices for the selective and precise particle-based thermal destruction of solid tumors. It develops AuroLase therapy, an investigational medical device that is used to ablate irregularly shaped tumors or inoperable solid tumors in refractory or recurrent head and neck cancer treatments. The company also develops and sells research-use-only nanoparticles with specific optical characteristics. Nanospectra Biosciences, Inc. was founded in 2002 and is based in Houston, Texas.
8285 El Rio Street
Houston, TX 77054
Founded in 2002
Key Executives for Nanospectra Biosciences, Inc.
Similar Private Companies By Industry
|Genico, Inc.||United States|
|Pulse Therapeutics, Inc.||United States|
|Titan Spine, LLC||United States|
|Velano Vascular, Inc.||United States|
|Medtronic Interventional Vascular Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Nanospectra Biosciences, Inc., please visit www.nanospectra.com. Company data is provided by Capital IQ. Please use this form to report any data issues.